Immediate Impact
58 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of A Dufour being referenced
Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A Dufour | 205 | 142 | 52 | 80 | 6 | 284 | |
| G. Bug | 233 | 97 | 50 | 86 | 7 | 283 | |
| Adil S. A. Al Hinai | 213 | 113 | 63 | 87 | 7 | 282 | |
| Torsten Haferlach | 172 | 103 | 25 | 43 | 5 | 228 | |
| J. Krauter | 189 | 109 | 38 | 89 | 8 | 228 | |
| Sally Jeffries | 176 | 63 | 57 | 55 | 10 | 225 | |
| Gudrun Mellert | 286 | 143 | 34 | 122 | 10 | 311 | |
| M. C. Sauerland | 218 | 118 | 21 | 65 | 7 | 234 | |
| Samuel Quentin | 178 | 130 | 34 | 84 | 9 | 278 | |
| Mara Molkentin | 150 | 86 | 25 | 83 | 6 | 245 | |
| Daniella Kerbauy | 221 | 87 | 22 | 142 | 6 | 270 |
All Works
Loading papers...